Genentech reveals Neosphere Phase II trial results
The data showed that the two antibodies plus docetaxel, given in the neoadjuvant setting prior to surgery, improved the rate of complete tumor disappearance in the breast by
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
The revised dosing recommendation extends the same dosing already approved for treatment-naive patients – Prezista, co-administered with ritonavir in combination with other antiretroviral agents and with food, once-daily
MorphoSys claims that Sloning’s Slonomics technology enables the precise construction of protein libraries comprising defined mixtures of amino acids at pre- determined positions with unprecedented speed. The MorphoSys